111 related articles for article (PubMed ID: 25577776)
1. Treatment of pheochromocytoma blockade of MAPK pathway inhibition in the NF-κB pathway and bFGF - effect of statins on pheochromocytoma patients.
Hu HJ; Zhou SH; Liu QM
Int J Cardiol; 2015 Mar; 182():161-2. PubMed ID: 25577776
[No Abstract] [Full Text] [Related]
2. Anti-cancer potential of MAPK pathway inhibition in paragangliomas-effect of different statins on mouse pheochromocytoma cells.
Fliedner SM; Engel T; Lendvai NK; Shankavaram U; Nölting S; Wesley R; Elkahloun AG; Ungefroren H; Oldoerp A; Lampert G; Lehnert H; Timmers H; Pacak K
PLoS One; 2014; 9(5):e97712. PubMed ID: 24846270
[TBL] [Abstract][Full Text] [Related]
3. Basic fibroblast growth factor induces VEGF expression in chondrosarcoma cells and subsequently promotes endothelial progenitor cell-primed angiogenesis.
Tzeng HE; Chen PC; Lin KW; Lin CY; Tsai CH; Han SM; Teng CL; Hwang WL; Wang SW; Tang CH
Clin Sci (Lond); 2015 Jul; 129(2):147-58. PubMed ID: 25735814
[TBL] [Abstract][Full Text] [Related]
4. Nck inhibits NGF and basic FGF induced PC12 cell differentiation via mitogen-activated protein kinase-independent pathway.
Rockow S; Tang J; Xiong W; Li W
Oncogene; 1996 Jun; 12(11):2351-9. PubMed ID: 8649775
[TBL] [Abstract][Full Text] [Related]
5. Blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-β as angiogenic factors in mouse osteosarcoma.
Tsubaki M; Yamazoe Y; Yanae M; Satou T; Itoh T; Kaneko J; Kidera Y; Moriyama K; Nishida S
Cytokine; 2011 Apr; 54(1):100-7. PubMed ID: 21292498
[TBL] [Abstract][Full Text] [Related]
6. Statins prevent NF-kappaB transactivation independently of the IKK-pathway in human endothelial cells.
Hölschermann H; Schuster D; Parviz B; Haberbosch W; Tillmanns H; Muth H
Atherosclerosis; 2006 Apr; 185(2):240-5. PubMed ID: 16051251
[TBL] [Abstract][Full Text] [Related]
7. Lead activates nuclear transcription factor-kappaB, activator protein-1, and amino-terminal c-Jun kinase in pheochromocytoma cells.
Ramesh GT; Manna SK; Aggarwal BB; Jadhav AL
Toxicol Appl Pharmacol; 1999 Mar; 155(3):280-6. PubMed ID: 10079214
[TBL] [Abstract][Full Text] [Related]
8. [Inoperable pheochromocytoma].
Lehtonen A; Auranen A
Duodecim; 1981; 97(23-24):1953-5. PubMed ID: 7344933
[No Abstract] [Full Text] [Related]
9. Breast cancer growth prevention by statins.
Campbell MJ; Esserman LJ; Zhou Y; Shoemaker M; Lobo M; Borman E; Baehner F; Kumar AS; Adduci K; Marx C; Petricoin EF; Liotta LA; Winters M; Benz S; Benz CC
Cancer Res; 2006 Sep; 66(17):8707-14. PubMed ID: 16951186
[TBL] [Abstract][Full Text] [Related]
10. Src and fibroblast growth factor 2 independently regulate signaling and gene expression induced by experimental injury to intact articular cartilage.
Watt FE; Ismail HM; Didangelos A; Peirce M; Vincent TL; Wait R; Saklatvala J
Arthritis Rheum; 2013 Feb; 65(2):397-407. PubMed ID: 23124605
[TBL] [Abstract][Full Text] [Related]
11. Fluvastatin inhibits high glucose-induced nuclear factor kappa B activation in renal tubular epithelial cells.
Gao P; Wu X; Shui H; Jia R
J Nephrol; 2013; 26(2):289-96. PubMed ID: 22641573
[TBL] [Abstract][Full Text] [Related]
12. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells.
Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW
Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111
[TBL] [Abstract][Full Text] [Related]
13. RhoA-mediated, tumor necrosis factor alpha-induced activation of NF-kappaB in rheumatoid synoviocytes: inhibitory effect of simvastatin.
Xu H; Liu P; Liang L; Danesh FR; Yang X; Ye Y; Zhan Z; Yu X; Peng H; Sun L
Arthritis Rheum; 2006 Nov; 54(11):3441-51. PubMed ID: 17075836
[TBL] [Abstract][Full Text] [Related]
14. Key role of nuclear factor-κB in the cellular pharmacokinetics of adriamycin in MCF-7/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2.
Zhang J; Lu M; Zhou F; Sun H; Hao G; Wu X; Wang G
Drug Metab Dispos; 2012 Oct; 40(10):1900-8. PubMed ID: 22745335
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of PC-12 cell differentiation by the immediate early gene fra-1.
Ito E; Sweterlitsch LA; Tran PB; Rauscher FJ; Narayanan R
Oncogene; 1990 Dec; 5(12):1755-60. PubMed ID: 2178237
[TBL] [Abstract][Full Text] [Related]
16. NF-κB, ERK, p38 MAPK and JNK contribute to the initiation and/or maintenance of mechanical allodynia induced by tumor necrosis factor-alpha in the red nucleus.
Zhang Q; Wang J; Duan MT; Han SP; Zeng XY; Wang JY
Brain Res Bull; 2013 Oct; 99():132-9. PubMed ID: 24161765
[TBL] [Abstract][Full Text] [Related]
17. [Effect of alpha-blocker and beta-blocker on in vitro pheochromocytoma tissue (author's transl)].
Nakai T; Yamada R
Nihon Naika Gakkai Zasshi; 1979 Jan; 68(1):43-53. PubMed ID: 422896
[No Abstract] [Full Text] [Related]
18. Biochemical mechanisms of bornyl caffeate induced cytotoxicity in rat pheochromocytoma PC12 cells.
Yang C; Zhao J; Pei W; Zheng X; Rong J
Chem Biol Interact; 2014 Aug; 219():133-42. PubMed ID: 24907532
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy trials in malignant pheochromocytoma: report of two patients and review of the literature.
Bukowski RM; Vidt DG
J Surg Oncol; 1984 Oct; 27(2):89-92. PubMed ID: 6237229
[TBL] [Abstract][Full Text] [Related]
20. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
